Plan Group Financial
AZN icon

Plan Group Financial’s AstraZeneca AZN Stock Holding History

Plan Group Financial’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-1,121
Closed -$213K – 232
2026
Q2 		$213K Sell
1,121
-750
-40% -$141K 0.04% 234
2026
Q1 		$369K Sell
1,871
-751
-29% -$145K 0.09% 145
2025
Q4 		$482K Buy
+2,622
New +$460K 0.13% 121

Other funds holding AZN

Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
M&G plc
M&G plc London, United Kingdom $19.9B AUM 15.09% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Plan Group Financial's AZN Position: Q3 2026 in Review

Plan Group Financial sold out of AstraZeneca (AZN) in Q3 2026, closing a stake of 1,121 shares — an estimated $213K sold.

Plan Group Financial first reported a position in AZN in Q4 2025 and held it in 3 quarters. The position peaked at $482K in Q4 2025. 736 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Plan Group Financial reported no remaining AstraZeneca position as of Q3 2026 after selling out during the quarter.
  • Plan Group Financial sold 1,121 AstraZeneca shares in Q3 2026, an estimated $213K.
  • Plan Group Financial first reported a position in AstraZeneca in Q4 2025 and held it in 3 quarters.
  • Plan Group Financial's AstraZeneca position peaked at $482K in Q4 2025.
  • 736 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Plan Group Financial's 13F filing for Q3 2026, filed 22 Oct 2026.